Shinya Goto Selected Research

Platelet Aggregation Inhibitors (Antiplatelet Drugs)

1/2017	Platelet receptors as therapeutic targets: Past, present and future.
12/2016	Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF.
1/2016	Targeting thrombin long-term after an acute coronary syndrome: Opportunities and challenges.
7/2014	[Historical and future perspective of antithrombotic agents].
8/2013	Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
1/2013	Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
9/2011	Risk factors and outcomes for patients with vascular disease and serious bleeding events.
4/2010	Basic principles of platelet biology and clinical implications.
11/2008	Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
1/2007	Are Japanese patients more prone to gastro-duodenal mucosal injury and bleeding with the use of antiplatelet agents?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinya Goto Research Topics

Disease

63	Stroke (Strokes) 01/2022 - 12/2005
52	Atrial Fibrillation 01/2022 - 11/2008
48	Hemorrhage 01/2022 - 12/2005
34	Thrombosis (Thrombus) 10/2022 - 07/2002
32	Myocardial Infarction 01/2020 - 03/2002
21	Acute Coronary Syndrome 01/2020 - 01/2009
19	Embolism (Embolus) 01/2022 - 09/2011
14	Heart Failure 06/2021 - 01/2003
14	Ischemic Stroke 11/2019 - 12/2006
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 09/2008
9	Venous Thromboembolism 08/2022 - 09/2016
9	Hypertension (High Blood Pressure) 02/2021 - 04/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 12/2005
8	Vascular Diseases (Vascular Disease) 02/2021 - 10/2009
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 01/2012
7	Diabetes Mellitus 02/2021 - 09/2008
7	Hemorrhagic Stroke 08/2017 - 09/2011
6	Unstable Angina 10/2021 - 03/2002
5	Transient Ischemic Attack 11/2019 - 12/2006
5	Peripheral Arterial Disease 04/2016 - 03/2013
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 01/2006
4	Disease Progression 01/2022 - 01/2017
4	Thromboembolism 02/2021 - 09/2014
4	Infections 01/2020 - 01/2017
4	Type 2 Diabetes Mellitus (MODY) 09/2019 - 11/2010
3	Deltaretrovirus Infections (BLV Infection) 01/2022 - 01/2018
3	Neoplasms (Cancer) 02/2021 - 01/2013
3	Paratuberculosis (Johne's Disease) 01/2020 - 01/2018
3	Thrombocytopenia (Thrombopenia) 01/2015 - 01/2003
3	Atherosclerosis 12/2014 - 08/2013
3	Ulcer 07/2014 - 06/2009
2	Overweight 12/2021 - 11/2010
2	Obesity 06/2021 - 07/2007
2	Anemia 01/2021 - 12/2016
2	Cerebral Hemorrhage 01/2021 - 12/2014
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2019
2	Persistent Infection 01/2020 - 01/2017
2	ST Elevation Myocardial Infarction 01/2019 - 05/2017
2	Dyslipidemias (Dyslipidemia) 01/2018 - 01/2014
2	Peptic Ulcer (Peptic Ulcers) 07/2014 - 05/2014
2	Wounds and Injuries (Trauma) 05/2014 - 09/2011
2	Ischemia 01/2014 - 05/2011

Drug/Important Bio-Agent (IBA)

44	AnticoagulantsIBA 08/2022 - 01/2008
26	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2020 - 01/2009
24	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 04/2010
22	Vitamin K FDA Link 01/2022 - 09/2011
15	apixabanIBA 01/2021 - 09/2011
14	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 08/2002
13	RivaroxabanIBA 05/2017 - 05/2011
11	Clopidogrel (Plavix)FDA Link 05/2017 - 01/2009
9	TicagrelorIBA 01/2020 - 07/2014
7	von Willebrand FactorIBA 10/2022 - 07/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 01/2006
6	Factor Xa InhibitorsIBA 02/2021 - 05/2011
6	Thrombin FDA Link 07/2019 - 01/2010
6	Thrombin Receptors (Thrombin Receptor)IBA 04/2016 - 01/2010
6	vorapaxarIBA 04/2016 - 02/2010
6	Adenosine Diphosphate (ADP)IBA 07/2014 - 01/2010
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 01/2004
5	Glycoproteins (Glycoprotein)IBA 01/2015 - 07/2002
4	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2020 - 02/2004
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2017 - 07/2013
4	Factor Xa (Coagulation Factor Xa)IBA 12/2016 - 01/2012
4	CreatinineIBA 05/2016 - 11/2010
4	E 5555IBA 07/2012 - 11/2010
3	AntithrombinsIBA 02/2021 - 03/2015
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2018 - 01/2017
3	omega-Chloroacetophenone (Mace)IBA 10/2017 - 02/2010
3	Peptide Hydrolases (Proteases)FDA Link 04/2016 - 01/2010
3	FibrinIBA 01/2016 - 01/2006
3	Prasugrel Hydrochloride FDA Link 01/2015 - 01/2013
3	Cilostazol (Pletal)FDA LinkGeneric 11/2009 - 12/2005
3	Platelet Membrane Glycoprotein IIbIBA 01/2006 - 03/2002
2	CollagenIBA 10/2022 - 07/2002
2	LipidsIBA 06/2021 - 04/2017
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 01/2006
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 12/2010
2	B7-H1 AntigenIBA 01/2019 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 05/2017 - 07/2012
2	Proton Pump InhibitorsIBA 05/2014 - 09/2011
2	thienopyridineIBA 03/2014 - 05/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014 - 07/2012
2	Antihypertensive Agents (Antihypertensives)IBA 08/2013 - 04/2013
2	rebamipideIBA 09/2011 - 06/2009
2	ThromboxanesIBA 12/2010 - 01/2010
2	Thromboplastin (Tissue Factor)IBA 01/2009 - 01/2006
2	CholesterolIBA 07/2007 - 12/2006
2	Glucose (Dextrose)FDA LinkGeneric 12/2006 - 01/2006

Therapy/Procedure

58	Therapeutics 12/2021 - 01/2006
11	Secondary Prevention 01/2020 - 12/2005
7	Percutaneous Coronary Intervention 10/2021 - 12/2010
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2021 - 05/2011
3	Carotid Endarterectomy 04/2017 - 12/2006
3	Stents 01/2017 - 08/2002
2	Lasers (Laser) 10/2022 - 01/2010
2	Blood Transfusion (Blood Transfusions) 02/2020 - 05/2015
2	Endarterectomy (Thromboendarterectomy) 04/2017 - 12/2006
2	Patient Readmission 04/2012 - 10/2009